Nevadistinel (NYX-458, NYX-3054) is a positive allosteric modulator of the N-methyl-D-aspartate (NMDA) receptor, indicated for mitigating cognitive deficits related to neurodegenerative conditions, including mild cognitive impairment, mild Alzheimers disease, Parkinsons disease, and Lewy body disease [1].
Molecular Weight:
274.32
CAS Number:
[2181816-92-0]
Formula:
C15H18N2O3
Target:
iGluR
T79855
* VAT and and shipping costs not included. Errors and price changes excepted